TGS Reintroduces Ramform Vanguard for Offshore Wind and Site Survey OSLO, Norway (6 March 2026) – TGS, a leading provider of energy data and intelligence, is pleased to announce a new acquisition campaign for the Ramform Vanguard during the upcoming European summer season, following its winter-stack period. The campaign is scheduled to begin in mid-March with an oil and gas site survey, before continuing with two offshore wind contracts. The current plan extends acquisition activities well into the third quarter. Kristian Johansen, CEO of TGS, commented, "We are very pleased to have secure...
SPIE - 2025 Full-Year results High-quality performance with outstanding cash generation Upgraded mid-term margin target Governance evolution, ensuring smooth transition and full strategic continuity Cergy, March 6th, 2026 Record profitability and solid revenue growth, pushing revenue well above the €10 bn mark Revenue: €10,380 million, up +4.8% vs. 2024, including +3.2% growth from acquisitions and +2.0% organic growth, with Germany confirmed as the Group’s primary growth driver (+5.3%), well supported by North-Western Europe (+4.3%)EBITA increased sharply by 11.4% to €793 million, ...
SPIE - Communiqué de presse Résultats FY 2025 Performance de grande qualité et génération de trésorerie exceptionnelle Relèvement de l’objectif de marge à moyen-terme Évolution de la gouvernance garantissant une transition fluide et une totale continuité stratégique Cergy, le 6 mars 2026 Rentabilité record et croissance solide portant la production bien au-dessus de la barre des 10 milliards d’euros Production : 10 380 millions d’euros, en hausse de +4,8 % par rapport à 2024, dont +3,2 % provenant des acquisitions et +2,0 % de croissance organique. L’Allemagne confirme s...
Evolution of SPIE’s governance Decision of Gauthier Louette not to seek the renewal of his mandates as Chairman and CEO at the end of his term in April 2026 Separation of the functions of Chairman of the Board of Directors and Chief Executive OfficerAppointment of Mr. Markus Holzke as Chief Executive Officer and Mr. Patrick Jeantet as non-executive Chairman of the Board Cergy, March 6th, 2026 Mr. Gauthier Louette has informed the Board of Directors of his decision not to seek the renewal of his functions of Chairman of the Board of Directors and Chief Executive Officer at the end of his ...
Évolution de la gouvernance de SPIE Décision de M. Gauthier Louette de ne pas solliciter le renouvellement de son mandat de Président directeur-général en avril 2026 Dissociation des fonctions de Président du Conseil d’administration et de Directeur général Désignation de M. Markus Holzke en tant que Directeur général et de M. Patrick Jeantet en tant que Président non-exécutif du Conseil d’administration Cergy, le 6 mars 2026 M. Gauthier Louette a informé le Conseil d’administration de sa décision de ne pas solliciter le renouvellement de ses fonctions de Président-directeur général à l’...
Hexagon Purus receive orders for delivery of hydrogen distribution units to a leading European energy company (Oslo, 6 March 2026) Hexagon Purus, a world leading manufacturer of zero emission mobility and infrastructure solutions, has received purchase orders for the delivery of hydrogen distribution units from a leading Central European integrated energy company. The total value of the order is approximately EUR 6.2 million and is scheduled for delivery in Q3 and Q4 2026. “We are happy to welcome this new customer and to provide distribution units that will transport hydrogen to this l...
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with ocular MG Additional data from ADAPT SERON – the largest study of patients with gMG who do not have detectable AChR-Ab – demonstrate VYVGART’s efficacy and safety across subtypesNew biomarker analysis, real-world evidence and post-hoc insights highlight VYVGART’s expanding treatment approach in CIDP March 6, 2026...
Fagron publishes its Annual Report 2025 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET Fagron publishes its Annual Report 2025 Fagron, the leading global player in pharmaceutical compounding, today publishes its Annual Report 2025, further to its earlier announcement of Fagron's annual financial results for the financial year 2025 on February 12, 2026. The Annual Report is available on Fagron's in both Dutch (official version, including the ESEF-tagged version) and English. It comprises the annual financial report relating to the consolidated f...
TomTom reported a 4Q25 update which was negative on the short term, but which did have some silver linings for the long term. We believe that TomTom's platform and market traction improved a lot, but we need to see more significant growth for operational leverage to kick in. We have lowered our short-term estimates but keep longer-term estimates largely unchanged. We reiterate our HOLD and €5.0 target price.
Philips reported a better-than-expected 4Q25 update and a supportive CMD message. We increase our estimates, raise our target price from €23 to €26 and reiterate our Hold rating. Philips appears positioned to continue progressing operationally, but we believe consistent delivery will be required before we see meaningful outperformance versus the sector. Valuation at 15x adj EPS 2027F is in line with peers.
Fagron publiceert haar Jaarverslag 2025 Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 6 maart 2026 – 7:00 CET Fagron publiceert haar Jaarverslag 2025 Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, publiceert vandaag haar Jaarverslag 2025, volgend op de eerdere bekendmaking van Fagron's jaarlijkse financiële resultaten over het boekjaar 2025 op 12 februari 2026. Het Jaarverslag is beschikbaar op de van Fagron in zowel het Nederlands (officiële versie, inclusief ESEF-getagde versie) als in het Engels. Het Jaarverslag omvat het financieel...
BFIT will report the FY25 results next week, 11 March while on 26 January it already published a trading update with an outlook for FY25 (excluding Clever Fit), a guidance for FY26 (including Clever Fit) and some details on Clever Fit. As such we are focussing on membership ingrowth trends in January/February/early March which we expect to be strong based on the latest Google Search trend data and the strong January trading update. We believe estimates for FY26F are still rather cautious, ie, be...
A director at B Investments Holding S.A.E bought 41,000 shares at 0.000EGP and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
A director at GB Corp bought 75,000 shares at 0.000EGP and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
A director at Valmore Holding sold 2,355,000 shares at 0.000USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
A director at Palm Hills Developments Company bought 550,000 shares at 0.000EGP and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
A director at Taaleem Management Services Co bought 170,762 shares at 0.000EGP and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
A director at Arab Valves Company bought 103,401 shares at 0.000EGP and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.